Abstract
Introduction: Macrophages play an important role in disease progression of pediatric cholestatic liver disease, particularly biliary atresia (BA); however, the restorative versus pathogenic role for precise macrophage subsets remains poorly defined. We aimed to distinguish the transcriptional profiles and roles of defined macrophage subset(s) in murine BA. Methods: We used multiparameter flow cytometry and RNA-sequencing analysis to profile recruited CD11bhiCD64+ hepatic macrophages by cell surface expression of MHCII and Ly6c in the Rhesus rotavirus (RRV)-induced murine model of BA versus saline controls. Modulation of macrophage numbers via intra-peritoneal injections of clodronate-loaded liposomes was performed to determine the association between macrophage numbers and histologic injury (Ishak score). Results: Ly6c+ macrophages demonstrated the greatest increase in numbers and percent of total macrophages in murine BA versus saline controls whereas MHCII+ macrophages decreased. Transcriptional changes in murine BA MHCII+ macrophages included reduced expression of the Kupffer cell gene signature, lower expression of genes involved in homeostatic processes, and increased expression of genes involved in inflammatory processes. Ly6c+ macrophages in murine BA showed increased expression for Hif1a and other genes involved in the cellular response to hypoxia. Among all subsets, the number of Ly6c+ macrophages exhibited the strongest correlation with severity of histologic liver injury by Ishak score. Conclusions: Our data identify specific pathways upregulated in Ly6c vs MHCII+ macrophage subsets in murine BA. Transcriptional similarities between murine BA and human cholestatic macrophages may enable translation of future mechanistic studies to new macrophage subset-specific therapies.
Original language | English (US) |
---|---|
Article number | 1506195 |
Journal | Frontiers in immunology |
Volume | 16 |
DOIs | |
State | Published - 2025 |
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Supported by the NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) K08 grant DK121937, National Institute of Allergy and Infectious Disease (NIAID) R21AI153747, the George Ferry Young Investigator Award from North American Society for Pediatric Gastroenterology Hepatology and Nutrition, the Pediatric Liver Research Fund from Lurie Children\u2019s Hospital Foundation in Chicago IL (ST); R01AI163742, R01AR080513, and American Heart Association (DW); Lupus Research Alliance Novel Research Grant, a Rheumatology Research Foundation Innovative Research Award, and a NIH NIAID R01AI170938 (CC). Acknowledgments Support for genomic sequencing and analysis was provided by the Metabolomics Core Facility at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Genomics Compute Cluster, which is jointly supported by the Feinberg School of Medicine, the Office of the Provost, the Office for Research, and Northwestern Information Technology.
Keywords
- cholestasis
- hepatic macrophages
- innate immunity
- obstructive cholangiopathy
- pediatric liver disease
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology